Your browser doesn't support javascript.
loading
Transcatheter Tricuspid Valve Intervention for the Treatment of Tricuspid Regurgitation with TriClip: All You Need to Know.
Matli, Kamal; Namnoum, Georges; Al-Osta, Soad; Masri, Alaa; Veugeois, Aurelie; Diakov, Christelle; Caussin, Christophe; Ghanem, Georges.
Affiliation
  • Matli K; Division of Cardiology, Department of Medicine, University of Montreal Hospital Centre, Montreal, Quebec, Canada.
  • Namnoum G; Cardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.
  • Al-Osta S; Department of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
  • Masri A; Cardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.
  • Veugeois A; Department of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
  • Diakov C; Cardiology Department, Lebanese American University Medical Center -Rizk Hospital, Beirut, Lebanon.
  • Caussin C; Department of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
  • Ghanem G; Department of Cardiovascular Medicine, Institut Mutualiste Montsouris, Paris, France.
Heart Int ; 18(1): 38-43, 2024.
Article in En | MEDLINE | ID: mdl-39006467
ABSTRACT
Severe tricuspid regurgitation (TR) is a common pathology in the daily practice of a cardiologist. This disease entity is associated with significant morbidity and mortality if left untreated. Classically, surgical repair or replacement were the only therapeutic options present and were often not performed due to high postprocedural mortality. Transcatheter tricuspid valve intervention has emerged as a novel and effective therapeutic option for the treatment of significant TR. Several devices have been developed with different mechanisms of action. In this review, we will provide an overview of transcatheter edge-to-edge repair of TR using the TriClip device (Abbott, Santa Clara, CA, USA).
Key words